885271-16-9 Usage
Uses
Used in Pharmaceutical Industry:
6-Bromo-3-phenyl-1H-indazole is used as a key intermediate in the synthesis of various pharmaceutical drugs. Its unique chemical structure allows for the development of new drug candidates with potential therapeutic applications.
Used in Organic Chemistry Research:
6-Bromo-3-phenyl-1H-indazole is used as a building block in the synthesis of complex organic molecules. Its reactivity and structural features make it a valuable compound for exploring new chemical reactions and pathways.
Used in Medicinal Chemistry:
6-Bromo-3-phenyl-1H-indazole is used as a scaffold in the design of new drug molecules. Its incorporation into drug candidates can potentially lead to the discovery of novel therapeutic agents with improved efficacy and safety profiles.
Note: The specific applications mentioned above are hypothetical and based on the general properties of 6-Bromo-3-phenyl-1H-indazole. More research and development are needed to validate these applications and understand the compound's full potential in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 885271-16-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,5,2,7 and 1 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 885271-16:
(8*8)+(7*8)+(6*5)+(5*2)+(4*7)+(3*1)+(2*1)+(1*6)=199
199 % 10 = 9
So 885271-16-9 is a valid CAS Registry Number.
885271-16-9Relevant academic research and scientific papers
Copper-Promoted Oxidative Intramolecular C–H Amination of Hydrazones to Synthesize 1H-Indazoles and 1H-Pyrazoles Using a Cleavable Directing Group
Zhang, Guofu,Fan, Qiankun,Zhao, Yiyong,Ding, Chengrong
supporting information, p. 5801 - 5806 (2019/08/02)
A facile and efficient synthesis of 1H-indazoles and 1H-pyrazoles through a copper-promoted oxidative intramolecular C–H amination of hydrazones using a cleavable directing group was developed. This reaction is characterized by its mild conditions, operational simplicity, readily available reagents, and excellent yields. A tentative mechanism for Cu-mediated C–H oxidative amination was proposed.
MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-κB ACTIVITY AND USE THEREOF
-
Page/Page column 123, (2008/12/05)
Novel non-steroidal compounds are provided which are useful in treating diseases associated with modulation of the glucocorticoid receptor, and/or AP-1, and/or NF-κB activity including inflammatory and immune diseases, obesity and diabetes having the structure of formula (I), its enantiomers, diastereomers, or a pharmaceutically-acceptable salt, or hydrate, thereof, wherein (Ia) is heterocycle or heteroaryl; J, Ja, E, F, G, Ma, M, Q, Za and Z are as defined herein. Also provided are pharmaceutical compositions and methods of treating inflammatory- or immune-associated diseases and obesity and diabetes employing said compounds.
